From these we derived a SCC cell line syngeneic to C57BL/6 recipients11,31,32 and used it as a tumor transplant model together with additional syngeneic transplant SCC models to assess if combined TGFβ inhibition and PD-L1 blockade induces durable tumor eradication. The gene discussed is CD274; the disease is neoplasm.